Samsung Electronics Co., Ltd.

Supadelixir Inc.

Kyoung-Jin Lee

Hyoung-seok Oh

Seung-Hee Lee

Joon-Hyung Park

Yun Soo Jang

Myeong-Ha Kye

Jang-Hee Hahn

Je-Hyung Yoon

Sang-Ik Cho

Ha-Neul Kim

Seung-Ju Lee

Hee-Mun Bang

Jehyung Yoon

Hyoung-Seok Oh

Sun-Hee Lee

Hyun-Mi Ju

Dong-Min Kang

A voltage converter includes a converting circuit and a switching control circuit, where the converting circuit includes an inductor connected to a switching node, a first switching device connected between the switching node and a common voltage and a second switching device connected to the switching node, where the first switching device charges the inductor and discharges the inductor in response to a control signal, and the switching control circuit generates the control signal by performing a PWM and a PFM based on a first sensing signal, a second sensing signal and a feedback signal, and adjusts a charging time of the inductor on a time basis, based on at least the input power supply voltage when the switching control circuit performs the PFM.

Voltage converter for power management

A voltage converter includes a driving device unit, a current sensing unit and a switching control circuit. The driving device unit charges an input power supply voltage in an inductor, connected between a switching node and an output node, in response to a first driving control signal, and discharges the inductor in response to a second driving control signal. The current sensing unit generates first and second sensing signals based on a first sensed current, a second sensed current, a voltage at the switching node and a ground voltage. The switching control circuit generates the first and second driving control signals by performing a pulse-frequency modulation (PFM) and a pulse-width modulation (PWM) based on a feedback voltage, a reference voltage and the first and second sensing signals. The switching control circuit adaptively adjusts off-time when the switching control circuit performs the PFM.

Voltage converter and power management device including the same

In a clock-based soft-start circuit configured to generate a soft-start reference voltage that restrains an inrush current at an initialization of power supplied to a DC-DC converter, the clock-based soft-start circuit comprises a time setting unit configured to set a soft-start time period in response to a clock signal. A ramp circuit is configured to generate a soft-start reference voltage which is ramped upward or downward between a base level and a reference voltage level during the soft start time period set by the time setting unit. In this manner, the clock-based soft-start circuit is applicable for all DC-DC converters and the soft-start in a linear slope is possible.

Clock-based soft-start circuit and power management integrated circuit device

A hybrid charge pump including a hybrid circuit configured to snub an over shoot or under shoot present in an input pulse in a snubbing operation if a level of the pulse is a first level, store the pulse in a charging operation if the level of the pulse is a second level different from the first level, and generate a negative voltage from the stored pulse in a negative voltage generation operation.

Hybrid charge pump and method for operating the same, power management IC comprising the pump

The present invention relates to a polypeptide derived from a highly conserved region (HCR) I-III of an extracellular region of a CD99 and CD99 family such as CD99L2 and PBDX(or XG), which are a kind of transmembrane protein, or a fused protein thereof. The polypeptide or the fused protein thereof has an activating function of inhibiting the extravasation of white blood cells, or inhibiting the growth and/or metastasis of cancer cells. The present invention also provides a polynucleotide coding the polypeptide, a vector including same, and a transformant transformed by the vector. In addition, the present invention provides a pharmaceutical composition including the polypeptide or the fused protein thereof for preventing or treating inflammatory diseases. Further, the present invention provides a is pharmaceutical composition including the polypeptide or the fused protein thereof inhibiting the growth and/or metastasis of cancer cells, i.e., a pharmaceutical composition for preventing or treating cancer.

Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis

Described is a polypeptide inhibiting the transmigration of leukocytes or the growth and/or metastasis of cancer cells, a fusion protein thereof, a polynucleotide encoding the polypeptide, a vector including the polynucleotide, and a transformant transformed with the vector. Described is also a pharmaceutical composition for the prevention or treatment of inflammatory diseases, or the inhibition of the growth and/or metastasis of cancer cells including the polypeptide or a fusion protein thereof.

Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof

Disclosed are a polarizer, a method for fabricating the same, and a liquid crystal display having the same. The liquid crystal display includes a liquid crystal panel and a polarizer attached to the liquid crystal panel. The polarizer includes a polarizing film, a first support film, and a second support film. The first support film has optical anisotropy and is attached to the polarizing film. The first support film has a first thickness. The second support film is attached to the polarizing film while facing the first support film and has a second thickness, which is greater than the first thickness. The polarizer is fabricated by evaporating a solvent from a solution including polymer resin to form an optical film and then elongating the optical film.

Growing community of inventors

Seoul, South Korea

Kyoung-Jin Lee